HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA
INBC 2025

Clinical efficacy analysis of implantable VNS stimulation rehabilitation therapy for the patients with hemiplegia after ischemic stroke

Speaker at Neurology Conferences - Dawei Zang
Capital Medical University, China
Title : Clinical efficacy analysis of implantable VNS stimulation rehabilitation therapy for the patients with hemiplegia after ischemic stroke

Abstract:

Purpose: Currently there are no effective rehabilitation therapies for the upper limb movement disorders of the patients after ischemic stroke in clinical; it is difficult for these patients to return to society and work. Implantable VNS (Vagus Nerve Stimulation?VNS) is widely used in the therapy of refractory epilepsy locally and internationally. Recent clinical studies have found that implantable VNS also has a clear therapeutic effect on upper limb movement disorders of the patients with ischemic stroke. We therefore investigated whether implantable VNS therapy can improve upper limb motor function, speech, and cognitive function in patients with ischemic stroke.

Method: 40 patients with ischemic stroke were selected to undergo the surgical operation of cervical vagus nerve implantation. After VNS operation, these patients accepted implantable VNS and conventional rehabilitation therapies for 6 months, FMRI, EEG and multiple rehabilitation scales were used to analyze whether there were statistical changes in the patients' upper limb motor dysfunction, speech, and cognitive function.

Result: Implantable VNS therapy has statistical significance in improving upper limb motor dysfunction, cognitive impairment, and motor aphasia in these ischemic stroke patients;

Conclusion: Implantable VNS therapy may become a potential rehabilitation therapy for the patients with ischemic stroke in the future, but its clinical rehabilitation value for lower limb motor dysfunction, sensory aphasia and dysarthria still requires further studies.

Biography:

Dr. Dawei ZANG studied clinical medicine at the Norman Bethune Medical University and graduated as MBBS in 1989, he studied neurology and neuroscience at the university of Melbourne, Australia, and graduated as PhD in 2004. He then backed to Beijing, China at Beijing Tiantan Hospital, Capital Medical University, he obtained the position of professor at the hospital in 2009, he has published more than 200 research and clinical papers in SCI or native journals, and has obtained more than 40 invention patents in neurological fields.

Watsapp